HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification for cataract: A meta-analysis and systematic review.

AbstractPurpose:
To compare the complications of femtosecond laser-assisted cataract surgery (FLACS) with those of conventional phacoemulsification surgery (CPS) for age-related cataracts.
Methods:
PubMed, Cochrane Library, and EMBASE were systematically searched for studies comparing FLACS and CPS. Outcomes were operative complications, including the intraoperative capsule tear, postoperative corneal edema, macular edema, uncontrolled IOP, etc. The effect measures were weighted with odds ratios with 95% CIs.
Results:
Nineteen RCTs and 18 cohort studies, including 24,806 eyes (11,375 of the FLACS group and 13,431 of the CPS group), were identified. There were no significant differences between the two groups in anterior capsule tear, corneal edema, macular edema, uncontrolled IOP, vitreous loss, posterior vitreous detachment, etc. Posterior capsule tear rate showed a significantly lower in RCT subgroups (P ​= ​0.04) and without differences in total (P ​= ​0.63). Significant differences were observed in the incidence of descemet membrane tear/trauma (P ​= ​0.02) and IFIS/iris trauma (P ​= ​0.04. Additionally, The FLACS specific complications showed a significantly higher rate of miosis (P ​< ​0.0001), corneal epithelial defect (P ​= ​0.001), corneal haze (P ​= ​0.002), and subconjunctival hemorrhage (P ​= ​0.01).
Conclusions:
FLACS maintains the same safety compared with CPS in terms of all intraoperative and postoperative complications. Although FLACS did show a statistically significant difference for several FLACS specific complications, it would not influence the visual outcome and heal itself.
AuthorsJingjie Xu, Xinyi Chen, Hanle Wang, Ke Yao
JournalAdvances in ophthalmology practice and research (Adv Ophthalmol Pract Res) 2022 May-Jun Vol. 2 Issue 1 Pg. 100027 ISSN: 2667-3762 [Electronic] United States
PMID37846222 (Publication Type: Journal Article, Review)
Copyright© 2022 The Authors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: